Binding free energy calculation with QM/MM hybrid methods for Abl-Kinase inhibitor
نویسندگان
چکیده
منابع مشابه
Rapid, concurrent and adaptive extreme scale binding free energy calculation
The recently demonstrated ability to perform accurate, precise and rapid computation of ligand binding strengths has driven interest in the use of molecular simulations for applications in both computeraided drug design and patient specific medicine. Simulation protocols based on ensembles of multiple runs of the same system provide an efficient method for producing robust free energy estimate,...
متن کاملElectronic Supplementary Information: Classical free energy calculation methods
The ensemble average is calculated as a time average from a molecular dynamics simulations in the canonical (NVT) ensemble. The coupling parameter, λ, is chosen such that the Hamiltonian is changed from describing the bound state to describing the free state of the Zn ion. If the transformation process is reversible, the free energy change is independent of the reaction path and only depends on...
متن کاملAssessing the efficiency of free energy calculation methods.
The efficiencies of two recently developed methods for calculating free energy changes along a generalized coordinate in a system are discussed in the context of other, related approaches. One method is based on Jarzynski's identity [Phys. Rev. Lett. 78, 2690 (1997)]. The second method relies on thermodynamic integration of the average force and is called the adaptive biasing force method [Darv...
متن کاملCalculation for Energy of (111) Surfaces of Palladium in Tight Binding Model
In this work calculation of energetics of transition metal surfaces is presented. The tight-binding model is employed in order to calculate the energetics. The tight-binding basis set is limited to d orbitals which are valid for elements at the end of transition metals series. In our analysis we concentrated on electronic effects at temperature T=0 K, this means that no entropic term will be pr...
متن کاملOverriding imatinib resistance with a novel ABL kinase inhibitor.
Resistance to the ABL kinase inhibitor imatinib (STI571 or Gleevec) in chronic myeloid leukemia (CML) occurs through selection for tumor cells harboring BCR-ABL kinase domain point mutations that interfere with drug binding. Crystallographic studies predict that most imatinib-resistant mutants should remain sensitive to inhibitors that bind ABL with less stringent conformational requirements. B...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Biological Physics
سال: 2010
ISSN: 0092-0606,1573-0689
DOI: 10.1007/s10867-010-9199-z